Post by Longwood Healthcare Leaders

The pharma and biotech #dealmaking landscape is shifting, and fast. After a period of recalibration marked by tighter capital markets, rising asset valuations, and a renewed scramble for late-stage pipeline, BD leaders are navigating more complex considerations than ever.   At #MITCEO this June 15-16, we look forward to hosting some of the industry’s top executives for candid, off-the-record discussions on where deals are being done, where they're falling apart, and what's driving decision-making at the highest levels.   Reserve your seat to join the conversation: https://lnkd.in/gNgNseFU Polly Brown Debbie Drane Alan Ginsberg Andrew Wong Bob Silverman  AstraZeneca CSL EMD Serono, Inc. Chugai Pharmaceutical Co., Ltd. Formation Bio  #Biotech #Pharma #BusinessDevelopment #Dealmaking #LifeSciences #Partnerships #Licensing